Saltar al contenido
Merck

Evolution, synthesis and SAR of tripeptide alpha-ketoacid inhibitors of the hepatitis C virus NS3/NS4A serine protease.

Bioorganic & medicinal chemistry letters (2002-02-15)
Stefania Colarusso, Benjamin Gerlach, Uwe Koch, Ester Muraglia, Immacolata Conte, Ian Stansfield, Victor G Matassa, Frank Narjes
RESUMEN

N-terminal truncation of the hexapeptide ketoacid 1 gave rise to potent tripeptide inhibitors of the hepatitis C virus NS3 protease/NS4A cofactor complex. Optimization of these tripeptides led to ketoacid 30 with an IC50 of 0.38 microM. The SAR of these tripeptides is discussed in the light of the recently published crystal structures of a ternary tripetide/NS3/NS4A complexes.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Methyl 4-(hydroxymethyl)benzoate, 98%